Tergus Lauded by Frost & Sullivan for Its Full-spectrum CRO Services for Therapeutics in Dermatology
Frost & Sullivan
MARCH 8, 2021
In June 2019, Tergus announced its partnership with Great Point Partners to raise capital, and a month later, purchased a 100,000 square foot facility near its headquarters. The company works with customers across business verticals such as generics and novel drugs, driven mainly by large pharma, specialty pharma, and biotech startups.
Let's personalize your content